CLGN News and Press, CollPlant Holdings Ltd. From 11/01/23

CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler PR Newswire - Intellectual Property Rights Secured in One of the Largest Target Markets for CollPlant's Potential Products - REHOVOT, Israel , Nov. 1, 2023 /PRNe...

CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative PR Newswire - As a new participant, the Company strengthens its commitment to operate sustainably and transition the regenerative and aesthetics medic...

CollPlant to Present at the H.C. Wainwright Annual Growth Conference PR Newswire REHOVOT, Israel , Sept. 5, 2023 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and produc...

2023-08-24 23:27:10 ET CollPlant Biotechnologies Ltd. (CLGN) Q2 2023 Earnings Conference Call August 24, 2023 10:00 ET Company Participants Dory Kurowski - Investor Relations Yehiel Tal - Chief Executive Officer Eran Rotem - Deputy Chief Executive Officer and Chi...

2023-08-24 10:00:34 ET Gainers: CollPlant Biotechnologies ( CLGN ) +11% NeuBase Therapeutics ( NBSE ) +7% NeuroPace ( NPCE ) +7% Bionomics ( BNOX ) +6% Enhabit ( EHAB ) +16% Losers: NanoVibronix ( NAOV ) -15% ...

2023-08-24 07:05:19 ET CollPlant Biotechnologies press release ( NASDAQ: CLGN ): Q2 Non-GAAP EPS of $0.52. Revenue of $10.2M (+14471.4% Y/Y) beats by $4.86M . Cash and cash equivalents totaled $22.3 million as of June 30, 2023; cash runway extended with additional ...

CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million PR Newswire Received in July 2023 , $10 million from partner, AbbVie, for achieving a major milestone in the second quarter, for the clinical-phase dermal ...

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION PR Newswire -  Conference call to be held on Thursday, August 24, 2023 at 10:00 a.m. U.S. EDT - REHOVOT, Israel , Aug. 9, 2023 /PRNe...

CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration Agreement PR Newswire REHOVOT, Israel , June 26, 2023 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerat...

2023-05-24 12:49:08 ET CollPlant Biotechnologies Ltd. (CLGN) Q1 2023 Earnings Conference Call May 24, 2023, 10:00 AM ET Company Participants Dory Kurowski - LifeSci Advisors Yehiel Tal - CEO Eran Rotem - Deputy CEO and CFO Conference Call Participants ...